Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

BETA 2-MICROGLOBULIN - ANVISA Registration 80785070145

Access comprehensive regulatory information for BETA 2-MICROGLOBULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80785070145 and manufactured by Vida Biotecnologia Ltda - ME. The registration is held by Vida Biotecnologia Ltda - ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80785070145
Registration Details
ANVISA Registration Number: 80785070145
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

VIDAFIAteste รŸ2MG
Risk Class II

Registration Details

80785070145

25351607912202191

11308834000185

Company Information

Brazil
PT: BRASIL

Dates and Status

Nov 04, 2021

VIGENTE

09/18/2025 19:00:01